BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23457483)

  • 1. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx.
    Singh A; Ramnath RD; Foster RR; Wylie EC; Fridén V; Dasgupta I; Haraldsson B; Welsh GI; Mathieson PW; Satchell SC
    PLoS One; 2013; 8(2):e55852. PubMed ID: 23457483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High glucose causes dysfunction of the human glomerular endothelial glycocalyx.
    Singh A; Fridén V; Dasgupta I; Foster RR; Welsh GI; Tooke JE; Haraldsson B; Mathieson PW; Satchell SC
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F40-8. PubMed ID: 20980411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro.
    Foster RR; Armstrong L; Baker S; Wong DW; Wylie EC; Ramnath R; Jenkins R; Singh A; Steadman R; Welsh GI; Mathieson PW; Satchell SC
    Am J Pathol; 2013 Aug; 183(2):604-16. PubMed ID: 23770346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier.
    Satchell SC; Braet F
    Am J Physiol Renal Physiol; 2009 May; 296(5):F947-56. PubMed ID: 19129259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.
    Singh A; Satchell SC; Neal CR; McKenzie EA; Tooke JE; Mathieson PW
    J Am Soc Nephrol; 2007 Nov; 18(11):2885-93. PubMed ID: 17942961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction.
    Ramnath R; Foster RR; Qiu Y; Cope G; Butler MJ; Salmon AH; Mathieson PW; Coward RJ; Welsh GI; Satchell SC
    FASEB J; 2014 Nov; 28(11):4686-99. PubMed ID: 25122554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limited role of the glomerular endothelial cell glycocalyx as a barrier to transglomerular albumin transport.
    Comper WD
    Connect Tissue Res; 2014; 55(1):2-7. PubMed ID: 24437598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol protects human glomerular endothelial cells from high glucose-induced reactive oxygen species generation, p53 overexpression and endothelial dysfunction.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Int Urol Nephrol; 2018 Jan; 50(1):179-186. PubMed ID: 29094329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties.
    Satchell SC; Anderson KL; Mathieson PW
    J Am Soc Nephrol; 2004 Mar; 15(3):566-74. PubMed ID: 14978158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of radiation-induced damage of human glomerular endothelial cells by SMPDL3B.
    Abou Daher A; Francis M; Azzam P; Ahmad A; Eid AA; Fornoni A; Marples B; Zeidan YH
    FASEB J; 2020 Jun; 34(6):7915-7926. PubMed ID: 32293077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative shedding of glycosaminoglycans from the endothelial glycocalyx during inflammation and their contribution to stiffness of the glycocalyx.
    Lipowsky HH
    Biorheology; 2019; 56(2-3):191-205. PubMed ID: 31707364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of glomerular endothelial hyaluronan in the development of proteinuria.
    Asai A; Hatayama N; Kamiya K; Yamauchi M; Kinashi H; Yamaguchi M; Katsuno T; Nobata H; Watanabe K; Wakatsuki A; Aten J; Maruyama S; Ishimoto T; Hirai S; Naito M; Ito Y
    Physiol Rep; 2021 Sep; 9(17):e15019. PubMed ID: 34472715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis.
    Rops AL; Loeven MA; van Gemst JJ; Eversen I; Van Wijk XM; Dijkman HB; van Kuppevelt TH; Berden JH; Rabelink TJ; Esko JD; van der Vlag J
    Kidney Int; 2014 Nov; 86(5):932-42. PubMed ID: 24759151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.
    van Gemst JJ; Kouwenberg M; Rops ALWMM; van Kuppevelt TH; Berden JH; Rabelink TJ; Loeven MA; van der Vlag J
    PLoS One; 2018; 13(9):e0201560. PubMed ID: 30248108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier.
    Jeansson M; Haraldsson B
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F111-6. PubMed ID: 16091582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx.
    Gouverneur M; Spaan JA; Pannekoek H; Fontijn RD; Vink H
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H458-2. PubMed ID: 16126814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy.
    Korakas E; Ikonomidis I; Markakis K; Raptis A; Dimitriadis G; Lambadiari V
    Curr Vasc Pharmacol; 2020; 18(6):619-631. PubMed ID: 31889495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
    Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
    Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases.
    Sol M; Kamps JAAM; van den Born J; van den Heuvel MC; van der Vlag J; Krenning G; Hillebrands JL
    Front Pharmacol; 2020; 11():573557. PubMed ID: 33123011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier.
    Khalil R; Boels MGS; ; van den Berg BM; Bruijn JA; Rabelink TJ; Hogendoorn PCW; Baelde HJ
    Mol Genet Genomics; 2022 Mar; 297(2):397-405. PubMed ID: 35103870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.